Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 4/2024

20-02-2024 | Acute Promyelocytic Leukemia | Letter to the Editor

A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration

Authors: Takayuki Goto, Nobuhiko Nakamura, Tomomi Suzaki, Ryoma Shimazu, Yuto Kaneda, Yoshikazu Ikoma, Takuro Matsumoto, Hiroshi Nakamura, Nobuhiro Kanemura, Masahito Shimizu

Published in: Annals of Hematology | Issue 4/2024

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
3.
Adler Y, Charron P, Imazio M et al (2015) 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the diagnosis and management of Pericardial diseases of the European Society of Cardiology (ESC)endorsed by: the European Association for Cardio-thoracic surgery (EACTS). Eur Heart J 36:2921–2964. https://​doi.​org/​10.​1093/​eurheartj/​ehv318CrossRefPubMed
4.
5.
6.
7.
8.
9.
Metadata
Title
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration
Authors
Takayuki Goto
Nobuhiko Nakamura
Tomomi Suzaki
Ryoma Shimazu
Yuto Kaneda
Yoshikazu Ikoma
Takuro Matsumoto
Hiroshi Nakamura
Nobuhiro Kanemura
Masahito Shimizu
Publication date
20-02-2024
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2024
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-024-05660-9

Other articles of this Issue 4/2024

Annals of Hematology 4/2024 Go to the issue

Original Article

Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma

Original Article

Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab

Research

Myelodysplasia-related gene mutations are associated with favorable prognosis in patients with TP53-mutant acute myeloid leukemia

Original Article

Recent trends in incidence, survival and treatment of multiple myeloma in Finland – a nationwide cohort study

Case Report

Isolated massive pleural effusion as a manifestation of chronic graft versus host disease successfully treated with corticosteroid

Original Article

Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits